Case Report

Gastric Carcinoid Tumor in Association with Hepatocellular Carcinoma: A Case Report

Authors: Athanasios Petrou, MD, Papalambros Alexandros, MD, Papaconstantinou Ioannis, MD, PhD, Sigala Frangiska, MD, PhD, Xiromeritis Kostantinos, MD, Felekouras Evangelos, MD, PhD, Papalambros Efstathios, MD, PhD


A second primary malignancy (SPM) can occur in patients with gastrointestinal carcinoids. A patient underwent endoscopic resection of a gastric carcinoid. Repeat gastroscopy revealed recurrence of the lesion and multiple nodular gastric lesions, while an abdominal computed tomography scan revealed a small solid lesion in the left hepatic lobe. The patient underwent total gastrectomy and wedge resection of what proved to be a hepatocellular carcinoma. This case illustrates the significance of considering SPM in every patient with gastrointestinal carcinoids. SPMs are more aggressive than carcinoids, and awareness and early resection of these tumors may improve prognosis.

This content is limited to qualifying members.

Existing members, please login first.

If you have an existing account please login now to access this article or view your purchase options.

Purchase only this article ($15)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.


1.Askanazy M. Zur Pathogenese der Magen-krebse und uber ihren gegentlichen Ursprung aus angeboren epithelialen Keimen in der Magenwand. Dtsch Med Wochenschr 1923;49:49–51.
2.Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003;97:934–959.
3.Rindi G, Luinetti O, Cornaggia M, et al. Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study. Gastroenterology 1993;104:994–1006.
4.Solcia E, Fiocca R, Sessa F, et al. Morphology and natural history of gastric endocrine tumors, in Hakanson R, Sundler F (eds): The Stomach as an Endocrine Organ. Amsterdam, Elsevier, 1991, pp 473–498.
5.Modlin IM, Lye KD, Kidd M. A 50-year analysis of 562 gastric carcinoids: small tumor or larger problem? Am J Gastroenterol 2004;99:23–32.
6.Godwin JD II. Carcinoid tumors. An analysis of 2837 cases. Cancer 1975;36:560–569.
7.Kothari T, Mangla JC. Malignant tumors associated with carcinoid tumors of the gastrointestinal tract. J Clin Gastroenterol 1981;3(suppl 1):43–46.
8.Morgan JG, Marks C, Hearn D. Carcinoid tumors of the gastrointestinal tract. Ann Surg 1974;180:720–727.
9.Habal N, Sims C, Bilchik AJ. Gastrointestinal carcinoid tumors and second primary malignancies. J Surg Oncol 2000;75:310–316.
10.Gerstle JT, Kauffman GL Jr, Koltun WA. The incidence, management, and outcome of patients with gastrointestinal carcinoids and second primary malignancies. J Am Coll Surg 1995;180:427–432.
11.Tichansky DS, Cagir B, Borrazzo E, et al. Risk of second cancers in patients with colorectal carcinoids. Dis Colon Rectum 2002;45:91–97.
12.Jordan PH Jr, Barroso A, Sweeney J. Gastric carcinoids in patients with hypergastrinemia. J Am Coll Surg 2004;199:552–555.
13.Zucker KA, Longo WE, Modlin IM, et al. Malignant diathesis from jejunal-ileal carcinoids. Am J Gastroenterol 1989;84:182–186.